189 related articles for article (PubMed ID: 32203130)
1. Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson's disease familial A53T mutation.
Sun Y; Hou S; Zhao K; Long H; Liu Z; Gao J; Zhang Y; Su XD; Li D; Liu C
Cell Res; 2020 Apr; 30(4):360-362. PubMed ID: 32203130
[No Abstract] [Full Text] [Related]
2. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy.
Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X
Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure.
Zhao K; Li Y; Liu Z; Long H; Zhao C; Luo F; Sun Y; Tao Y; Su XD; Li D; Li X; Liu C
Nat Commun; 2020 May; 11(1):2643. PubMed ID: 32457390
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface.
Sun C; Zhou K; DePaola P; Shin WS; Hillyer T; Sawaya MR; Zhu R; Peng C; Zhou ZH; Jiang L
J Biol Chem; 2023 Apr; 299(4):104566. PubMed ID: 36871760
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM structure of alpha-synuclein fibrils.
Guerrero-Ferreira R; Taylor NM; Mona D; Ringler P; Lauer ME; Riek R; Britschgi M; Stahlberg H
Elife; 2018 Jul; 7():. PubMed ID: 29969391
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.
Zhao K; Lim YJ; Liu Z; Long H; Sun Y; Hu JJ; Zhao C; Tao Y; Zhang X; Li D; Li YM; Liu C
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20305-20315. PubMed ID: 32737160
[TBL] [Abstract][Full Text] [Related]
7. The hereditary mutation G51D unlocks a distinct fibril strain transmissible to wild-type α-synuclein.
Sun Y; Long H; Xia W; Wang K; Zhang X; Sun B; Cao Q; Zhang Y; Dai B; Li D; Liu C
Nat Commun; 2021 Oct; 12(1):6252. PubMed ID: 34716315
[TBL] [Abstract][Full Text] [Related]
8. The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.
Boyer DR; Li B; Sun C; Fan W; Zhou K; Hughes MP; Sawaya MR; Jiang L; Eisenberg DS
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3592-3602. PubMed ID: 32015135
[TBL] [Abstract][Full Text] [Related]
9. Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy.
Flynn JD; McGlinchey RP; Walker RL; Lee JC
J Biol Chem; 2018 Jan; 293(3):767-776. PubMed ID: 29191831
[TBL] [Abstract][Full Text] [Related]
10. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
[TBL] [Abstract][Full Text] [Related]
11. Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.
Boyer DR; Li B; Sun C; Fan W; Sawaya MR; Jiang L; Eisenberg DS
Nat Struct Mol Biol; 2019 Nov; 26(11):1044-1052. PubMed ID: 31695184
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of the Relative Fragmentation Stabilities of Polymorphic Alpha-Synuclein Amyloid Fibrils.
Sanami S; Purton TJ; Smith DP; Tuite MF; Xue WF
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625557
[TBL] [Abstract][Full Text] [Related]
13. Mutations associated with familial Parkinson's disease alter the initiation and amplification steps of α-synuclein aggregation.
Flagmeier P; Meisl G; Vendruscolo M; Knowles TP; Dobson CM; Buell AK; Galvagnion C
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10328-33. PubMed ID: 27573854
[TBL] [Abstract][Full Text] [Related]
14. Structural Insights of Fe
Zhao Q; Tao Y; Zhao K; Ma Y; Xu Q; Liu C; Zhang S; Li D
J Mol Biol; 2023 Jan; 435(1):167680. PubMed ID: 35690099
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insight into the relationship between N-terminal acetylation of α-synuclein and fibril formation rates by NMR and fluorescence.
Kang L; Janowska MK; Moriarty GM; Baum J
PLoS One; 2013; 8(9):e75018. PubMed ID: 24058647
[TBL] [Abstract][Full Text] [Related]
16. Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations.
Ni X; McGlinchey RP; Jiang J; Lee JC
J Mol Biol; 2019 Sep; 431(19):3913-3919. PubMed ID: 31295458
[TBL] [Abstract][Full Text] [Related]
17. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy.
Guerrero-Ferreira R; Taylor NM; Arteni AA; Kumari P; Mona D; Ringler P; Britschgi M; Lauer ME; Makky A; Verasdonck J; Riek R; Melki R; Meier BH; Böckmann A; Bousset L; Stahlberg H
Elife; 2019 Dec; 8():. PubMed ID: 31815671
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease.
de Oliveira GAP; Silva JL
Commun Biol; 2019; 2():374. PubMed ID: 31633065
[TBL] [Abstract][Full Text] [Related]
19. Cryo-Electron Microscopy Uncovers Key Residues within the Core of Alpha-Synuclein Fibrils.
Chakraborty R; Chattopadhyay K
ACS Chem Neurosci; 2019 Mar; 10(3):1135-1136. PubMed ID: 30785257
[TBL] [Abstract][Full Text] [Related]
20. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
Ghosh D; Sahay S; Ranjan P; Salot S; Mohite GM; Singh PK; Dwivedi S; Carvalho E; Banerjee R; Kumar A; Maji SK
Biochemistry; 2014 Oct; 53(41):6419-21. PubMed ID: 25268550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
